Search

Author/Creator Araki, Eiichi

11. Clinical profiles of hyperglycemic crises: A single‐center retrospective study from Japan. Issue 8 (8th January 2021)

Authors:
Nishikawa, Takeshi; Kinoshita, Hiroyuki; Ono, Keiko; Kodama‐Hashimoto, Shoko; Kobayashi, Yuka; Nakamura, Tomofumi; Yoshinaga, Tomoaki; Ohkubo, Yuma; Harada, Masahiro; Toyonaga, Tetsushi; Takahashi, Takeshi; Araki, Eiichi
Journal:
Journal of diabetes investigation
Issue:
Volume 12:Issue 8(2021)
Page Start:
1359
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

12. Coexistence of resistance to thyroid hormone and papillary thyroid carcinoma. (1st May 2016)

Authors:
Igata, Motoyuki; Tsuruzoe, Kaku; Kawashima, Junji; Kukidome, Daisuke; Kondo, Tatsuya; Motoshima, Hiroyuki; Shimoda, Seiya; Furukawa, Noboru; Nishikawa, Takeshi; Miyamura, Nobuhiro; Araki, Eiichi
Journal:
Endocrinology, diabetes & metabolism case reports
Issue:
(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. Comparison of the efficacy of sitagliptin and glimepiride dose‐up in Japanese patients with type 2 diabetes poorly controlled by sitagliptin and glimepiride in combination. Issue 3 (22nd October 2013)

Authors:
Shimoda, Seiya; Iwashita, Shinsuke; Sekigami, Taiji; Furukawa, Noboru; Matsuo, Yasuto; Ichimori, Shinji; Goto, Rieko; Maeda, Takako; Watanabe, Eiichiro; Kondo, Tatsuya; Matsumura, Takeshi; Motoshima, Hiroyuki; Nishida, Kenro; Araki, Eiichi
Journal:
Journal of diabetes investigation
Issue:
Volume 5:Issue 3(2014:Jun.)
Page Start:
320
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. Effects of a novel selective peroxisome proliferator‐activated receptor‐α modulator, pemafibrate, on hepatic and peripheral glucose uptake in patients with hypertriglyceridemia and insulin resistance. Issue 6 (26th April 2018)

Authors:
Matsuba, Ikuro; Matsuba, Ren; Ishibashi, Shun; Yamashita, Shizuya; Arai, Hidenori; Yokote, Koutaro; Suganami, Hideki; Araki, Eiichi
Journal:
Journal of diabetes investigation
Issue:
Volume 9:Issue 6(2018)
Page Start:
1323
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

15. Effects of K-877, a novel selective PPARα modulator (SPPARMα), in dyslipidaemic patients: A randomized, double blind, active- and placebo-controlled, phase 2 trial. (June 2016)

Authors:
Ishibashi, Shun; Yamashita, Shizuya; Arai, Hidenori; Araki, Eiichi; Yokote, Koutaro; Suganami, Hideki; Fruchart, Jean-Charles; Kodama, Tatsuhiko
Journal:
Atherosclerosis
Issue:
Volume 249(2016)
Page Start:
36
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

16. Effects of Selective PPARα Modulator K-877 on Particle Numbers of Lipoprotein Subclasses in Dyslipidemic Patients: Analysis by GP-HPLC and NMR Lipoprofile 2 and 3. (June 2018)

Authors:
Yamashita, Shizuya; Okazaki, Mitsuyo; Okada, Takeshi; Masuda, Daisaku; Arai, Hidenori; Yokote, Koutaro; Araki, Eiichi; Ishibashi, Shun
Journal:
Atherosclerosis
Issue:
Volume 32(2018)
Page Start:
62
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

17. Efficacy and safety of dapagliflozin in addition to insulin therapy in Japanese patients with type 2 diabetes: Results of the interim analysis of 16‐week double‐blind treatment period. Issue 4 (22nd January 2016)

Authors:
Araki, Eiichi; Onishi, Yukiko; Asano, Michiko; Kim, Hyosung; Ekholm, Ella; Johnsson, Eva; Yajima, Toshitaka
Journal:
Journal of diabetes investigation
Issue:
Volume 7:Issue 4(2016:Aug.)
Page Start:
555
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

18. Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT‐5): 52‐week results from a randomized, open‐label, phase III clinical trial. Issue 4 (26th December 2019)

Authors:
Araki, Eiichi; Watada, Hirotaka; Uchigata, Yasuko; Tomonaga, Osamu; Fujii, Hitomi; Ohashi, Hiroshi; Okabe, Tadashi; Asano, Michiko; Thoren, Fredrik; Kim, Hyosung; Yajima, Toshitaka; Langkilde, Anna Maria
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 22:Issue 4(2020)
Page Start:
540
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

19. Efficacy and safety of dapagliflozin over 1 year as add‐on to insulin therapy in Japanese patients with type 2 diabetes: the DAISY (Dapagliflozin Added to patients under InSulin therapY) trial. Issue 4 (23rd February 2017)

Authors:
Araki, Eiichi; Onishi, Yukiko; Asano, Michiko; Kim, Hyosung; Yajima, Toshitaka
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 19:Issue 4(2017)
Page Start:
562
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

20. Efficacy and safety of K-877, a novel selective peroxisome proliferator-activated receptor α modulator (SPPARMα), in combination with statin treatment: Two randomised, double-blind, placebo-controlled clinical trials in patients with dyslipidaemia. (June 2017)

Authors:
Arai, Hidenori; Yamashita, Shizuya; Yokote, Koutaro; Araki, Eiichi; Suganami, Hideki; Ishibashi, Shun
Journal:
Atherosclerosis
Issue:
Volume 261(2017)
Page Start:
144
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗